CLINICAL AND SUBCLINICAL FEATURES OF PATIENTS PRESENTED WITH CERVICAL LYMPH NODE METASTASES AT NATIONAL CANCER HOSPITAL
Main Article Content
Abstract
Objective: Describing the clinical and subclinical features of patietns presented with cervical lymph node metastases at National Cancer Hospital from 01/2022 to 08/2022 and evaluating the primary tumors of those patients. Patients and method: Descriptive and prospective study of 72 patients presented with cervical lymph node metastases at the time of diagnosis at National Cancer Hospital from 01/2022 to 08/2022. Results: Male patients were dominated (72.2%) and 77.8% of patients were less than 65 years old. Most of patients have history of smoking and/or drinking. ECOG 1 accounted for 59.7%. Bilateral cervical nodes were common (59.7%), the most common location metastatic nodes was upper jugular node (59.7%), then submandibular node (51.4%), suppraclavicular node was accounted for 37.5%. The most common histology was squamous cell carcinoma (58.2%), then adenocarcinoma was accounted for 34.7%. For evaluating the primary tumors, rate of head and neck cancers was 51.4% of cases, then lung cancer (22.2%), and rate of unknown primary was 13.9%. Conclusion: Cervical node metastatic patients presented with various clinical symptoms, and high rate of bilateral metastases. Head and neck squamous cell carcinoma was the most common tumors, and 13.9% of cases diagnosed of unknown primary cancers despite of using diagnosis methods.
Article Details
Keywords
Cervical lymph node metastases, head and neck cancer, cancer of unknown primary
References
2. Nguyen, C., et al. (1994), "Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites", Head Neck. 16(1), pp. 58-63.
3. Strojan, P. and Anicin, A. (1998), "Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumour", Radiother Oncol. 49(1), pp. 33-40.
4. Issing, W. J., Taleban, B., and Tauber, S. (2003), "Diagnosis and management of carcinoma of unknown primary in the head and neck", Eur Arch Otorhinolaryngol. 260(8), pp. 436-43.
5. Guntinas-Lichius, O., et al. (2006), "Diagnostic work-up and outcome of cervical metastases from an unknown primary", Acta Otolaryngol. 126(5), pp. 536-44.
6. Zhuang, Shi Min, et al. (2014), "Management of lymph node metastases from an unknown primary site to the head and neck (Review)", Mol Clin Oncol. 2(6), pp. 917-922.
7. López, F., et al. (2016), "Cervical lymph node metastases from remote primary tumor sites", Head Neck. 38 Suppl 1(Suppl 1), pp. E2374-85.
8. Flörke, C., et al. (2021), "Clinicopathological Risk Factors for Contralateral Lymph Node Metastases in Intraoral Squamous Cell Carcinoma: A Study of 331 Cases", Curr Oncol. 28(3), pp. 1886-1898.
9. Garrel, R., et al. (2011), "Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature", Eur Ann Otorhinolaryngol Head Neck Dis. 128(3), pp. 115-9.
10. Lodder, W. L., et al. (2008), "Selective neck dissection for N0 and N1 oral cavity and oropharyngeal cancer: are skip metastases a real danger?", Clin Otolaryngol. 33(5), pp. 450-7.